Comeback of ketamine: resurfacing facts and dispelling myths

Initially known as CI-581, ketamine was first synthesized in 1962 as a replacement from phencyclidine. It has since been used as an anesthetic and analgesic. In addition, it has bronchodilating, sedative, and amnestic properties, preserving airway reflexes and sympathetic nervous system tone. Since...

Full description

Bibliographic Details
Main Authors: Abhijit Kumar, Amit Kohli
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2021-04-01
Series:Korean Journal of Anesthesiology
Subjects:
Online Access:http://ekja.org/upload/pdf/kja-20663.pdf
_version_ 1818726177981857792
author Abhijit Kumar
Amit Kohli
author_facet Abhijit Kumar
Amit Kohli
author_sort Abhijit Kumar
collection DOAJ
description Initially known as CI-581, ketamine was first synthesized in 1962 as a replacement from phencyclidine. It has since been used as an anesthetic and analgesic. In addition, it has bronchodilating, sedative, and amnestic properties, preserving airway reflexes and sympathetic nervous system tone. Since the discovery of ketamine, it has been a major topic of discussion due to controversies regarding its usage in particular sets of patients. In the past 50 years, despite its potential benefits, it is not commonly used because of concerns of “emergence phenomenon,” its use as a substance of abuse, and its systemic side effects. Since 2012, three World Health Organization reviews on ketamine have addressed its international control. Researchers have been studying this wonder drug for a decade worldwide. Many myths of ketamine regarding emergence phenomenon and its use in traumatic brain injury and open eye injury have been disproved in recent times. It is becoming popular in pre-hospital settings, critical care, emergency medicine, low-dose acute pain services, and adjuvant in regional anesthesia techniques. This review highlights the current consensus on the various applications of ketamine in the literature.
first_indexed 2024-12-17T21:54:04Z
format Article
id doaj.art-144c0f6d7d784612af3523e099535579
institution Directory Open Access Journal
issn 2005-6419
2005-7563
language English
last_indexed 2024-12-17T21:54:04Z
publishDate 2021-04-01
publisher Korean Society of Anesthesiologists
record_format Article
series Korean Journal of Anesthesiology
spelling doaj.art-144c0f6d7d784612af3523e0995355792022-12-21T21:31:10ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632021-04-0174210311410.4097/kja.206638718Comeback of ketamine: resurfacing facts and dispelling mythsAbhijit Kumar0Amit Kohli1 Department of Anesthesiology, VMMC and Safdarjung Hospital, New Delhi, India Department of Anesthesiology, Maulana Azad Medical College, New Delhi, IndiaInitially known as CI-581, ketamine was first synthesized in 1962 as a replacement from phencyclidine. It has since been used as an anesthetic and analgesic. In addition, it has bronchodilating, sedative, and amnestic properties, preserving airway reflexes and sympathetic nervous system tone. Since the discovery of ketamine, it has been a major topic of discussion due to controversies regarding its usage in particular sets of patients. In the past 50 years, despite its potential benefits, it is not commonly used because of concerns of “emergence phenomenon,” its use as a substance of abuse, and its systemic side effects. Since 2012, three World Health Organization reviews on ketamine have addressed its international control. Researchers have been studying this wonder drug for a decade worldwide. Many myths of ketamine regarding emergence phenomenon and its use in traumatic brain injury and open eye injury have been disproved in recent times. It is becoming popular in pre-hospital settings, critical care, emergency medicine, low-dose acute pain services, and adjuvant in regional anesthesia techniques. This review highlights the current consensus on the various applications of ketamine in the literature.http://ekja.org/upload/pdf/kja-20663.pdfacuteantidepressantscancer painhallucinationsintracranial pressureintraocular pressureketaminepain clinicsstatus epilepticus
spellingShingle Abhijit Kumar
Amit Kohli
Comeback of ketamine: resurfacing facts and dispelling myths
Korean Journal of Anesthesiology
acute
antidepressants
cancer pain
hallucinations
intracranial pressure
intraocular pressure
ketamine
pain clinics
status epilepticus
title Comeback of ketamine: resurfacing facts and dispelling myths
title_full Comeback of ketamine: resurfacing facts and dispelling myths
title_fullStr Comeback of ketamine: resurfacing facts and dispelling myths
title_full_unstemmed Comeback of ketamine: resurfacing facts and dispelling myths
title_short Comeback of ketamine: resurfacing facts and dispelling myths
title_sort comeback of ketamine resurfacing facts and dispelling myths
topic acute
antidepressants
cancer pain
hallucinations
intracranial pressure
intraocular pressure
ketamine
pain clinics
status epilepticus
url http://ekja.org/upload/pdf/kja-20663.pdf
work_keys_str_mv AT abhijitkumar comebackofketamineresurfacingfactsanddispellingmyths
AT amitkohli comebackofketamineresurfacingfactsanddispellingmyths